Supplementary Table S1 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer

crossref(2023)

引用 0|浏览5
暂无评分
摘要

Representativeness of Study Participants

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要